Omnitrope is Canada's first "Subsequent Entry Biologic"

February 2010

Omnitrope is Canada's first "Subsequent Entry Biologic....

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Cardiology backpedalling on aspirin to prevent heart disease
Diabetes Januvia (sitagliptin) is now approved for monotherapy for type 2 diabetes
Diabetes A1C to DIAGNOSE diabetes
Diabetes how to choose a blood glucose meter
Osteoporosis Aclasta (zoledronic acid) as a SINGLE IV infusion to PREVENT osteoporosis
Dermatology Dr. Scholl's Skin Tag Remover product
Respiratory & Allergy more COPD patients using inhaled tiotropium (Spiriva)
meds to prevent altitude illness before going on their big ski trip or mountain trek
Psychiatry concerns about whether antidepressants can increase the risk for stroke, heart disease, or death
Omnitrope is Canada's first "Subsequent Entry Biologic"
Cardiology how to dose meds for systolic heart failure
Supplements colon and liver "cleansers"
Infectious Diseases whether patients with breast or other cosmetic implants should get antibiotics before dental work
New Drugs chart of new drugs approved by Health Canada in 2009 is ready for you